The effect of (60)Co gamma rays irradiation on the polymetallayne [-Pt(PBu(3))-C≡C-C(6)H(4)-C(6)H(4)-C≡C-](n) (Pt-DEBP) of defined chain length corresponding to 10 repeat units, has been studied in detail. The UV-vis absorption spectra of Pt-DEBP have been recorded in solution upon exposure of the polymetallayne at increasing radiation doses in the range up to 90 Gy, with special care to the features related to low doses. Complex modifications of the chemical structure of Pt-DEBP could be accessed through NMR, FTIR, GPC, and XPS characterizations, which support the attack of Cl and H radicals coming from the radiolysis of the solvent, CHCl(3), to the triple C≡C bonds of the backbone, leading to the formation of chlorinated double and single C-C bonds, with a concomitant increase of the molecular weight due to a recombinant effect of oligomer fragments upon irradiation. The presence of vinyl and single chlorinated moieties has been sustained from the simulation of the UV-vis spectra based on theoretical calculations.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/jp3060747 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Analysis Method of 131I Activity in Carbon Cartridge and Internal Dose Assessment for Nuclear Medicine Workers.
Health Phys
January 2025
National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention, Beijing, 100088, China.
Inhalation of 131I is the main route for internal doses to nuclear medicine workers. This study aimed to establish a simple analysis method for determining 131I activity in carbon cartridges, explore the activity concentration of 131I in nuclear medicine departments, and evaluate the internal dose of workers. A total of 21 nuclear medicine departments in the hospital conducted air sampling using a high-volume air sampler equipped with carbon cartridges and glass fiber filters to collect gaseous 131I and aerosol 131I, respectively.
View Article and Find Full Text PDFAspirin use reduces cancer risk in betel nut chewers: a nationwide population-based cohort study.
Am J Cancer Res
December 2024
Department of Otorhinolaryngology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital Yilan 265, Taiwan.
Betel nut chewing, common in several Asian populations, is linked to increased cancer risk, including oral, esophageal, gastric, and hepatocellular carcinoma. Aspirin shows potential as a chemopreventive agent. This study investigates the association between aspirin use and cancer risk among betel nut chewers.
View Article and Find Full Text PDFRadioprotective Effects of Vitamin C, Cimetidine, and Famotidine on Lipid Peroxidase and Hepatic Glutathione Levels in Mouse Liver.
Int J Cell Biol
January 2025
Department of Biotechnology and Plant Breeding, Sari Agricultural Sciences and Natural Resources University (SANRU), Sari, Iran.
Radiation therapy is one of the most effective treatments for approximately 60% of patients with cancer. During radiation exposure, the overproduction of reactive oxygen species (ROS) disrupts the lipid layer of the membrane, leading to subsequent peroxide radical formation. Cimetidine (Cim) and famotidine (Fam) are histamine H2 receptor antagonists (H2 blocker), also known as peptic ulcer drugs, that exert radioprotective effects.
View Article and Find Full Text PDFVariations in linear energy transfer distributions within a European proton therapy planning comparison of paediatric posterior fossa tumours.
Phys Imaging Radiat Oncol
October 2024
Aarhus University Hospital, Danish Centre for Particle Therapy, Aarhus N, Denmark.
Background And Purpose: Radiotherapy for paediatric posterior fossa tumours may cause complications in the brainstem and upper spinal cord due to high doses. With proton therapy (PT) this risk may increase due to higher relative biological effectiveness (RBE) from elevated linear energy transfer (LET). This study assesses variations in LET in the brainstem and spinal cord in proton treatment plans from European centres.
View Article and Find Full Text PDFCombining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1-Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study.
JTO Clin Res Rep
January 2025
Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York City, NY, USA.
Introduction: WT1 often presents on the surface of diffuse pleural mesotheliomas (DPMs) and is an ideal therapeutic target. Galinpepimut-S (GPS), a tetravalent, non-human leukocyte antigen-restricted, heteroclitic WT1-specific peptide vaccine was safe and effective in early phase clinical trials and upregulates T-cell suppressive programmed death-ligand 1 in the tumor microenvironment of other malignancies. A randomized phase 2 study of adjuvant GPS in patients with DPM trended toward improved median overall survival.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!